Drug Type Peptide drug conjugates |
Synonyms HRC4 lipopeptide |
Target |
Action inhibitors |
Mechanism Viral fusion proteins inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Measles | Preclinical | France | 28 Oct 2022 |





